.RESEARCH STUDY FEATURE.06 August 2024.
A large randomized measured trial with cisgender ladies highlights the obstacles of obedience to a regular dental preexposure prophylaxis regiment and also illustrates that twice-yearly treatment of lenacapavir can easily sustain effective HIV protection levels over 6 months.